Catherine Skari

PYRUVATE KINASE DEFICIENCY | FDA Approves First Drug For The Rare Inherited Anemia

The US Food and Drug Administration (FDA) has announced the approval of Mitapivat (PYRUKYND®) tablets as treatment for haemolytic anemia…

Read More »

Delegation Visit to Pakistan – 27-29 November 2015

TIF was invited to participate in the faculty of speakers at 10th National Thalassaemia Conference, organised by the Thalassaemia Federation…

Read More »

Delegation Visit to Azerbaijan – 16-18 November 2015

TIF organised a delegation visit to Baku,  between the 16th and 18th of November 2015, with a view to revisiting…

Read More »

Delegation Visit to Germany – 24-27 September 2015

TIF has completed a delegation visit to Germany between 24-27 September 2015, represented by Mr George Constantinou, TIF Board Member.…

Read More »

Delegation Visit to Iran – 16-18 September 2015

  TIF conducted a delegation visit to Iran, between 16-18 September 2015, after receiving an invitation by medical specialists of…

Read More »

TIF INTERNATIONAL CONFERENCE | 19-21 November 2021

Read More »

Bluebird puts €1.58m price on gene therapy Zynteglo

  Bluebird bio Inc. set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five…

Read More »

SCD e-Course for Healthcare Professionals

Read More »

1st Global Annual IASG Meeting

Read More »

TIF’s Global Thalassaemia Review High-level Event: The Premiere

Read More »